|
US1005853A
(en)
|
1911-06-24 |
1911-10-17 |
Louis B Lewis |
Educational toy.
|
|
US3686412A
(en)
|
1965-03-25 |
1972-08-22 |
Colin Fitzmaurice |
Compositions containing bis-chromonyl compounds for inhibiting antigen-antibody reactions
|
|
GB1144905A
(en)
|
1965-03-25 |
1969-03-12 |
Fisons Pharmaceuticals Ltd |
Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
|
|
US3957965A
(en)
*
|
1967-08-08 |
1976-05-18 |
Fisons Limited |
Sodium chromoglycate inhalation medicament
|
|
GB1242211A
(en)
|
1967-08-08 |
1971-08-11 |
Fisons Pharmaceuticals Ltd |
Pharmaceutical composition
|
|
GB1257162A
(https=)
|
1968-02-16 |
1971-12-15 |
|
|
|
US4405598A
(en)
|
1976-01-30 |
1983-09-20 |
Fisons, Limited |
Composition for treating asthma
|
|
US4120285A
(en)
|
1976-11-01 |
1978-10-17 |
Owens-Illinois, Inc. |
Modular tubular solar energy collector apparatus
|
|
DE3104294A1
(de)
|
1981-02-07 |
1982-08-19 |
Hoechst Ag, 6000 Frankfurt |
Substituierte diazaspirodecane, ihre herstellung, ihre verwendung als stabilisatoren fuer organische polymere, sowie die so stabilisierten polymeren
|
|
US4429545A
(en)
|
1981-08-03 |
1984-02-07 |
Ocean & Atmospheric Science, Inc. |
Solar heating system
|
|
BE897058A
(fr)
|
1982-06-25 |
1983-12-16 |
Sandoz Sa |
Utilisation d'un derive du spiro-succinimide dans le traitement de la demence du type alzheimer
|
|
US4996296A
(en)
|
1983-07-27 |
1991-02-26 |
Yeda Research & Development Co., Ltd. |
Cromolyn binding protein in highly purifed form, and methods for the isolation thereof
|
|
JPH0662601B2
(ja)
|
1985-08-16 |
1994-08-17 |
京都薬品工業株式会社 |
クロモグリク酸誘導体および抗アレルギ−剤
|
|
US4919915A
(en)
|
1987-03-03 |
1990-04-24 |
Paul Averback |
Method for detecting the ability to prevent red-to-green congophilic birefringence
|
|
US5231170A
(en)
*
|
1986-08-27 |
1993-07-27 |
Paul Averback |
Antibodies to dense microspheres
|
|
CA2058764A1
(en)
|
1989-04-28 |
1990-10-29 |
Peter D. Hodson |
Dry powder inhalation device
|
|
US5376386A
(en)
|
1990-01-24 |
1994-12-27 |
British Technology Group Limited |
Aerosol carriers
|
|
DE4405387A1
(de)
|
1994-02-19 |
1995-08-24 |
Hoechst Ag |
Verfahren zur Herstellung von Polyalkyl-1-oxa-diazaspirodecan-Verbindungen
|
|
US6168776B1
(en)
|
1994-07-19 |
2001-01-02 |
University Of Pittsburgh |
Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
|
|
TR199600329A2
(tr)
|
1995-05-05 |
1997-03-21 |
Hoffmann La Roche |
Seker alkollerin yeni sülfürik asit esterleri.
|
|
US6026809A
(en)
|
1996-01-25 |
2000-02-22 |
Microdose Technologies, Inc. |
Inhalation device
|
|
US6126919A
(en)
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
|
AU756693B2
(en)
|
1997-09-29 |
2003-01-23 |
Novartis Ag |
Stabilized bioactive preparations and methods of use
|
|
US5904937A
(en)
|
1997-10-03 |
1999-05-18 |
Fmc Corporation |
Taste masked pharmaceutical compositions
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
DE69928928T2
(de)
|
1998-06-12 |
2006-08-03 |
Microdose Technologies Inc. |
Vorrichtung zur abgabe von arzneimitteln
|
|
US6197963B1
(en)
|
1998-08-13 |
2001-03-06 |
The Trustees Of The University Of Pennsylvania |
Non-peptide peptidomimetics
|
|
PL200941B1
(pl)
*
|
1998-11-13 |
2009-02-27 |
Jagotec Ag |
Suchy proszkowy preparat inhalacyjny
|
|
AU775914B2
(en)
|
1998-12-24 |
2004-08-19 |
Janssen Pharmaceutica N.V. |
Controlled release galantamine composition
|
|
JP2001151673A
(ja)
|
1999-09-06 |
2001-06-05 |
Nikken Chem Co Ltd |
吸入用粉末製剤の製造方法
|
|
US20020107173A1
(en)
|
1999-11-04 |
2002-08-08 |
Lawrence Friedhoff |
Method of treating amyloid beta precursor disorders
|
|
US20020009491A1
(en)
|
2000-02-14 |
2002-01-24 |
Rothbard Jonathan B. |
Compositions and methods for enhancing drug delivery across biological membranes and tissues
|
|
JP5025871B2
(ja)
|
2000-02-21 |
2012-09-12 |
エイチ．リュンドベック エイ／エス |
アミロイドの新規なダウン−レギュレート方法
|
|
US20080021085A1
(en)
|
2000-04-13 |
2008-01-24 |
Mayo Foundation For Medical Education And Research |
Method of reducing abeta42 and treating diseases
|
|
JP2003530437A
(ja)
|
2000-04-13 |
2003-10-14 |
マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチ |
Ａβ４２低下物質
|
|
PE20011227A1
(es)
|
2000-04-17 |
2002-01-07 |
Chiesi Farma Spa |
Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
|
|
MY120279A
(en)
|
2000-05-26 |
2005-09-30 |
Pharmacia Corp |
Use of a celecoxib composition for fast pain relief
|
|
US20020016359A1
(en)
|
2000-06-29 |
2002-02-07 |
Hellberg Mark R. |
Compositions and methods of treating neurodegenerative diseases
|
|
US8519005B2
(en)
|
2000-07-27 |
2013-08-27 |
Thomas N. Thomas |
Compositions and methods to prevent toxicity of antiinflammatory agents and enhance their efficacy
|
|
FR2815030A1
(fr)
|
2000-10-05 |
2002-04-12 |
Lipha |
Derives nitroso de la diphenylamine, compositions pharmaceutiques les contenant et leur utilisation pour la preparation de medicaments
|
|
US6511960B2
(en)
|
2001-01-05 |
2003-01-28 |
Alphamed Pharmaceuticals Corp |
Cromolyn for eye and ear infections
|
|
CA2444214A1
(en)
|
2001-04-23 |
2002-10-31 |
The Trustees Of The University Of Pennsylvania |
Amyloid plaque aggregation inhibitors and diagnostic imaging agents
|
|
CA2466863A1
(en)
|
2001-11-29 |
2003-06-05 |
Emisphere Technologies, Inc. |
Oral pharmaceutical compositions comprising cromolyn sodium and an acylated amino acid
|
|
ES2337350T3
(es)
|
2002-05-10 |
2010-04-23 |
Oriel Therapeutics, Inc. |
Inhalador de polvo seco para uso con medios de dispensacion activados por polimeros piezoelectricos y envases de blisteres asociado que comprende un material polimerico piezoelectrico.
|
|
EP1601380A1
(en)
|
2003-02-13 |
2005-12-07 |
Licentia OY |
Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of cerebral ischemia
|
|
WO2004071532A1
(en)
|
2003-02-13 |
2004-08-26 |
Licentia Oy |
Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of a patient subjected to thrombolyses
|
|
US20040223918A1
(en)
|
2003-05-07 |
2004-11-11 |
Chrysalis Technologies Incorporated |
Aerosolization of cromolyn sodium using a capillary aerosol generator
|
|
GB0321607D0
(en)
|
2003-09-15 |
2003-10-15 |
Vectura Ltd |
Manufacture of pharmaceutical compositions
|
|
JP4471340B2
(ja)
|
2003-10-07 |
2010-06-02 |
芦森工業株式会社 |
バックル装置
|
|
JP2007509941A
(ja)
*
|
2003-10-28 |
2007-04-19 |
グラクソ グループ リミテッド |
ラクトース無水物を用いる吸入医薬製剤およびその投与方法
|
|
GB0326632D0
(en)
*
|
2003-11-14 |
2003-12-17 |
Jagotec Ag |
Dry powder formulations
|
|
DE10355559A1
(de)
|
2003-11-21 |
2005-06-23 |
Orthogen Ag |
Transskin
|
|
US8088935B2
(en)
|
2003-12-23 |
2012-01-03 |
Ironwood Pharmaceuticals, Inc. |
Compounds and methods for the treatment of asthma
|
|
WO2005077394A1
(en)
|
2004-02-11 |
2005-08-25 |
Ramot At Tel-Aviv University Ltd |
Compositions for treatment of cancer and inflammation with curcumin and at least one nsaid
|
|
US20050182044A1
(en)
|
2004-02-17 |
2005-08-18 |
Bruinsma Gosse B. |
Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate
|
|
WO2006001877A2
(en)
|
2004-04-13 |
2006-01-05 |
Myriad Genetics, Inc. |
Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
|
|
CN101098678A
(zh)
|
2004-04-23 |
2008-01-02 |
锡德克斯公司 |
含有磺基烷基醚环糊精的dpi制剂
|
|
DE602005019582D1
(de)
|
2004-08-30 |
2010-04-08 |
Seo Hong Yoo |
Nervenschutzwirkung von aufgelöster udca bei einem fokalen ischämischen modell
|
|
JP2008518935A
(ja)
|
2004-11-01 |
2008-06-05 |
セオ ホン ユー |
筋萎縮性側索硬化症の神経退行を減少させるための方法及び組成物
|
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
|
ZA200708857B
(en)
|
2005-04-22 |
2009-01-28 |
Genentech Inc |
Method for treating dementia or alzheimer's disease with a CD30 antibody
|
|
CA2609980C
(en)
|
2005-05-27 |
2015-10-13 |
Queen's University At Kingston |
Treatment of protein folding disorders
|
|
CA2631493A1
(en)
|
2005-12-15 |
2007-06-21 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
|
|
US8263645B2
(en)
|
2006-02-03 |
2012-09-11 |
Pari Pharma Gmbh |
Disodium cromoglycate compositions and methods for administering same
|
|
AR059356A1
(es)
|
2006-02-14 |
2008-03-26 |
Astrazeneca Ab |
Nuevos radioligandos
|
|
DE602007009807D1
(de)
*
|
2006-03-06 |
2010-11-25 |
Raqualia Pharma Inc |
Sulfonylbenzimidazolderivate
|
|
CN103054837A
(zh)
|
2006-03-09 |
2013-04-24 |
瓦拉塔药品公司 |
用于治疗蛋白积聚病症的环己烷多元醇制剂
|
|
WO2008118122A2
(en)
|
2006-05-08 |
2008-10-02 |
Molecular Neuroimaging, Llc |
Compounds and amyloid probes thereof for therapeutic and imaging uses
|
|
US8445437B2
(en)
|
2006-07-27 |
2013-05-21 |
The Brigham And Women's Hospital, Inc. |
Treatment and prevention of cardiovascular disease using mast cell stabilizers
|
|
US20100173960A1
(en)
|
2006-09-21 |
2010-07-08 |
Antonio Cruz |
The Combination of a Cyclohexanehexol and a NSAID for the Treatment of Neurodegenerative Diseases
|
|
WO2008061373A1
(en)
|
2006-11-24 |
2008-05-29 |
Waratah Pharmaceuticals Inc. |
Combination treatments for alzheimer's disease and similar diseases
|
|
US20080292625A1
(en)
|
2007-04-18 |
2008-11-27 |
Sally Schroeter |
Prevention and treatment of cerebral amyloid angiopathy
|
|
ES2468551T3
(es)
|
2007-04-18 |
2014-06-16 |
Probiodrug Ag |
Derivados de nitrovinil-diamina como inhibidores de la glutaminil ciclasa
|
|
US7858803B2
(en)
|
2007-04-27 |
2010-12-28 |
The General Hospital Corporation |
Imaging tracers for early detection and treatment of amyloid plaques caused by Alzheimer's disease and related disorders
|
|
JP2010533181A
(ja)
|
2007-07-13 |
2010-10-21 |
アボツト・バイオテクノロジー・リミテツド |
ＴＮＦα阻害剤の肺投与のための方法及び組成物
|
|
GB0714134D0
(en)
|
2007-07-19 |
2007-08-29 |
Norton Healthcare Ltd |
Dry-powder medicament
|
|
DK2182983T3
(da)
|
2007-07-27 |
2014-07-14 |
Janssen Alzheimer Immunotherap |
Behandling af amyloidogene sygdomme med humaniserede anti-abeta antistoffer
|
|
JO3076B1
(ar)
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
|
EP3231804B1
(en)
|
2008-03-21 |
2021-03-03 |
The General Hospital Corporation |
Compounds and compositions for the detection and treatment of alzheimer's disease and related disorders
|
|
WO2009133128A1
(en)
|
2008-04-29 |
2009-11-05 |
Pharnext |
Combination compositions for treating alzheimer disease and related disorders with zonisamide and acamprosate
|
|
CA2747801A1
(en)
|
2009-01-22 |
2010-07-29 |
Raqualia Pharma Inc. |
N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
|
|
US8381454B1
(en)
|
2009-01-23 |
2013-02-26 |
Markus R. Robinson |
Segmented, elongated, expandable, 4-season, double-walled, low-cost, rigid extruded plastic panel structures
|
|
US8617517B2
(en)
*
|
2009-01-29 |
2013-12-31 |
The General Hospital Corporation |
Cromolyn derivatives and related methods of imaging and treatment
|
|
US9925282B2
(en)
|
2009-01-29 |
2018-03-27 |
The General Hospital Corporation |
Cromolyn derivatives and related methods of imaging and treatment
|
|
TWI541021B
(zh)
|
2009-03-05 |
2016-07-11 |
艾伯維有限公司 |
Ｉｌ－１７結合蛋白
|
|
AU2010224184A1
(en)
|
2009-03-11 |
2011-09-29 |
Plexxikon, Inc. |
Pyrrolo [2, 3-b] pyridine derivatives for the inhibition of Raf kinases
|
|
WO2010107702A1
(en)
*
|
2009-03-16 |
2010-09-23 |
Ipintl, Llc |
Treating alzheimer's disease and osteoporosis and reducing aging
|
|
PL2248517T3
(pl)
|
2009-05-08 |
2014-08-29 |
Pari Pharma Gmbh |
Stężone formulacje farmaceutyczne stabilizujące komórki tuczne
|
|
BR112012002333A2
(pt)
|
2009-08-06 |
2017-07-18 |
Neuraltus Pharmaceuticals Inc |
método de reduzir os efeitos colaterais e método de potencializar o efeito de um imunomodulador administrado a um sujeito que dele necessita; métodos para tratar doença associada com excesso de ativação de monócitos para macrófagos ativados, diabetes tipo ii ou complicações relacionadas, doença associada com a migração de monócitos ou macrófagos ativados, doença associada a excesso de produção de scd14 e/ou scd163 por macrófagos ativados; composto de cloreto de sódio; composição farmacêutica; método para diagnosticar uma doença relacionada com macrófagos em um sujeito; e método para determinar a eficácia do tratamento com um agente oxidante para uma doença relacionada a macrófagos em um sujeito.
|
|
WO2011032164A2
(en)
|
2009-09-14 |
2011-03-17 |
Kmetovicz Ronald E |
Solar heat pipe heat exchanger
|
|
MX355627B
(es)
|
2009-09-24 |
2018-04-25 |
Wista Lab Ltd |
Clorhidratos de metiltioninio (azul de metileno) cristalinos.
|
|
EP2322163A1
(en)
|
2009-11-03 |
2011-05-18 |
Pharnext |
New therapeutics approaches for treating alzheimer disease
|
|
WO2011057199A1
(en)
|
2009-11-06 |
2011-05-12 |
Adenios, Inc. |
Compositions for treating cns disorders
|
|
MX337603B
(es)
|
2009-11-30 |
2016-03-10 |
Adare Pharmaceuticals Inc |
Composiciones y tabletas farmaceuticas con recubrimiento compresible y metodos de fabricacion.
|
|
US8455755B2
(en)
|
2009-12-07 |
2013-06-04 |
Electrotherm |
Concentrated photovoltaic and thermal solar energy collector
|
|
EP2377860A1
(en)
|
2010-04-16 |
2011-10-19 |
AC Immune S.A. |
Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
|
|
WO2011136754A1
(en)
|
2010-04-26 |
2011-11-03 |
Mahmut Bilgic |
A medicament developed for the treatment of respiratory diseases
|
|
JP2013533320A
(ja)
|
2010-08-12 |
2013-08-22 |
レバレジオ コーポレイション |
タウオパチーを治療するための組成物および方法
|
|
RU2580890C2
(ru)
*
|
2010-09-30 |
2016-04-10 |
КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. |
Применение стеарата магния в составах сухого порошка для ингаляции
|
|
US20120121656A1
(en)
|
2010-11-15 |
2012-05-17 |
Revalesio Corporation |
Methods and compositions for protecting against neurotoxicity of a neurotoxic agent, and improving motor coordination associated with a neurodegenerative condition or disease
|
|
JP5898701B2
(ja)
|
2011-02-11 |
2016-04-13 |
ウィスタ ラボラトリーズ リミテッド |
フェノチアジンジアミニウム塩およびそれらの使用
|
|
SG11201406142XA
(en)
|
2012-03-27 |
2014-10-30 |
Univ Duke |
Compositions and methods for the prevention and treatment of mast cell-induced vascular leakage
|
|
JP2015518006A
(ja)
*
|
2012-05-25 |
2015-06-25 |
エクスクリア インコーポレイテッド |
キシリトール系の抗粘膜組成物及び関連する方法並びに組成物
|
|
US9655977B2
(en)
|
2012-08-31 |
2017-05-23 |
The General Hospital Corporation |
Biotin complexes for treatment and diagnosis of alzheimer's disease
|
|
WO2014065275A1
(ja)
|
2012-10-23 |
2014-05-01 |
国立大学法人福井大学 |
腫瘍融解症候群の治療薬及び予防薬
|
|
US10058530B2
(en)
|
2012-10-25 |
2018-08-28 |
The General Hospital Corporation |
Combination therapies for the treatment of Alzheimer's disease and related disorders
|
|
EP3563849A3
(en)
|
2012-10-25 |
2020-02-12 |
The General Hospital Corporation |
Combination therapies for the treatment of alzheimer's disease and related disorders
|
|
US10525005B2
(en)
|
2013-05-23 |
2020-01-07 |
The General Hospital Corporation |
Cromolyn compositions and methods thereof
|
|
WO2015002703A1
(en)
|
2013-05-23 |
2015-01-08 |
Aztherapies, Inc |
Methods for delivering cromolyn
|
|
CN110305095A
(zh)
|
2013-10-22 |
2019-10-08 |
综合医院公司 |
色甘酸衍生物以及成像和治疗的相关方法
|
|
PL3104853T3
(pl)
|
2014-02-10 |
2020-05-18 |
Respivant Sciences Gmbh |
Leczenie stabilizatorami komórek tucznych zaburzeń ogólnoustrojowych
|
|
ES2792682T3
(es)
|
2014-02-10 |
2020-11-11 |
Respivant Sciences Gmbh |
Métodos para el tratamiento de enfermedades pulmonares con estabilizadores de mastocitos
|
|
CN107735077A
(zh)
|
2014-11-21 |
2018-02-23 |
拜尔哈文制药股份有限公司 |
利鲁唑的舌下给药
|
|
US11723864B2
(en)
|
2015-05-29 |
2023-08-15 |
The Texas A&M University System |
Antimicrobial and anti-inflammatory compositions
|
|
US10238625B2
(en)
|
2015-08-07 |
2019-03-26 |
Respivant Sciences Gmbh |
Methods for the treatment of mast cell related disorders with mast cell stabilizers
|
|
WO2017027402A1
(en)
|
2015-08-07 |
2017-02-16 |
Patara Pharma, LLC |
Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
|
|
WO2017072335A1
(en)
|
2015-10-28 |
2017-05-04 |
Ab Science |
Use of masitinib and other mast cell inhibitors for treatment of parkinson's disease
|
|
MX2018006247A
(es)
|
2015-11-19 |
2018-11-29 |
Aztherapies Inc |
Metodos para tratar la enfermedad de alzheimer y trastornos relacionados.
|
|
US20180344682A1
(en)
|
2015-11-23 |
2018-12-06 |
Aztherapies, Inc. |
Compositions and methods for treating ischemic stroke
|
|
SG11201808106YA
(en)
|
2016-03-25 |
2018-10-30 |
Ab Science |
Use of masitinib for treatment of an amyotrophic lateral sclerosis patient subpopulation
|
|
JP2019524865A
(ja)
|
2016-08-31 |
2019-09-05 |
ザ ジェネラル ホスピタル コーポレイション |
神経変性疾患と関連する神経炎症におけるマクロファージ／ミクログリア
|
|
US10501527B2
(en)
|
2016-09-08 |
2019-12-10 |
Emergo Therapeutics, Inc. |
Mast cell stabilizers for treatment of hypercytokinemia and viral infection
|
|
JP7202376B2
(ja)
|
2017-07-20 |
2023-01-11 |
エーゼットセラピーズ， インコーポレイテッド |
クロモリンナトリウムおよびイブプロフェンの粉末製剤
|
|
CN108164409B
(zh)
|
2018-01-24 |
2021-06-18 |
温州医科大学 |
一种2-亚苄基-1-茚酮类似物及应用
|
|
AU2019251191A1
(en)
|
2018-04-09 |
2020-10-29 |
The General Hospital Corporation |
Combination therapies for the treatment of amyotropic lateral sclerosis and related disorders
|
|
CN108403708B
(zh)
|
2018-05-22 |
2019-06-14 |
滨州医学院 |
秦皮苷在制备预防或治疗急性呼吸窘迫综合征药物中的应用
|
|
AU2019299347A1
(en)
|
2018-07-02 |
2021-01-21 |
Aztherapies, Inc. |
Powdered formulations of cromolyn sodium and alpha-lactose
|
|
JP2021535181A
(ja)
|
2018-09-05 |
2021-12-16 |
ザ ジェネラル ホスピタル コーポレイション |
サイトカイン放出症候群を処置する方法
|
|
MX2021006869A
(es)
|
2018-12-10 |
2021-07-02 |
Massachusetts Gen Hospital |
Esteres de cromolin y usos de los mismos.
|
|
WO2021207060A1
(en)
|
2020-04-06 |
2021-10-14 |
The General Hospital Corporation |
Methods of treatment of coronavirus-induced inflammation conditions
|
|
WO2021248022A1
(en)
|
2020-06-04 |
2021-12-09 |
The General Hospital Corporation |
Methods of treating a coronavirus infection
|
|
WO2022146914A1
(en)
|
2020-12-28 |
2022-07-07 |
The General Hospital Corporation |
Cromolyn derivatives and uses thereof
|